Philippine News Agency
Vax experts to endorse shorter interval between 2nd dose, booster
Health Secretary Francisco Duque III announced that the vaccine expert panel is set to recommend a three-month interval between the second dose of the primary vaccination series and a COVID-19 booster shot.
This recommendation, which could apply to all approved vaccine brands, is a shortening from the previously considered six-month interval.
Health Undersecretary Maria Rosario Vergeire stated that pronouncements on the shortened interval are still considered theoretical as evidence on its efficacy is incomplete.
Previously, a shortened interval for boosters was only recommended for immunocompromised individuals.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The country's vaccine experts panel will recommend shortening the interval between the primary series and booster shots to three months from the previous six months, in light of the Omicron variant threat.
Read more →
The Food and Drug Administration (FDA) has approved a shorter interval of three months between the last primary dose and the booster shot for COVID-19 vaccines.
Read more →
As of now, only individuals who received Janssen or Sputnik Light single-dose COVID-19 vaccines are permitted to get booster shots three months after their initial vaccination.
Read more →
Presidential Adviser for Entrepreneurship Joey Concepcion is pushing for a faster rollout of COVID-19 booster shots in the Philippines due to the Omicron variant threat.
Read more →
The Philippines has shortened the waiting period for COVID-19 vaccine booster shots to three months after the second dose for fully vaccinated adults, as approved by the Food and Drug Administration (FDA).
Read more →